Lactic Acid Bacteria

 Kaneka has concluded a license agreement with ABB to give Kaneka the rights for production and sales of ABB's products in the US, Canada and Japan.

Kaneka invests in AB-Biotics SA biotech company

By Jim Cornall

Japanese company Kaneka Corporation has acquired a 34.8% share of AB-Biotics (ABB), a Spanish biotech company focusing on research, development and distribution of its own products using lactic acid bacteria.